(ATXI) – FDA
-
Avenue Therapeutics (ATXI) Reports Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101
-
Avenue Therapeutics (ATXI) Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ATXI Stock Lookup